Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Research ArticleInvited Perspectives

Metabolic Tumor Volume: We Still Need a Platinum-Standard Metric

Andrea Gallamini and Lale Kostakoglu
Journal of Nuclear Medicine February 2017, 58 (2) 196-197; DOI: https://doi.org/10.2967/jnumed.116.184663
Andrea Gallamini
1Antoine Lacassagne Cancer Center, Nice, France; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lale Kostakoglu
2Mount Sinai Medical Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 58 no. 2 196-197
DOI 
https://doi.org/10.2967/jnumed.116.184663
PubMed 
28151415

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication October 18, 2016
  • Accepted for publication October 24, 2016
  • Published online February 1, 2017.

Article Versions

  • previous version (November 10, 2016 - 04:55).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2017 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

Statistics from Altmetric.com

Cited By...

  • 2 Citations
  • 4 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • [18F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives
    Salim Kanoun, Cedric Rossi, Olivier Casasnovas
    Cancers 2018 10 5
  • Reply to the letter
    Hajira Ilyas, N. George Mikhaeel, Joel T. Dunn, Fareen Rahman, Henrik Møller, Daniel Smith, Sally F. Barrington
    European Journal of Nuclear Medicine and Molecular Imaging 2018 45 10
  • Artificial Intelligence/Machine Learning in Nuclear Medicine and Hybrid Imaging
    Georgios Kaissis, Rickmer Braren
    2022
  • Hodgkin Lymphoma
    Paul J. Bröckelmann, Lena Specht
    2020

Article usage

Article usage: November 2016 to December 2022

AbstractFullPdf
Nov 20160065
Dec 20160010
Jan 2017505
Feb 201737235151
Mar 201717157
Apr 201702718
May 201733218
Jun 201732816
Jul 201731916
Aug 201702921
Sep 201712110
Oct 201701910
Nov 201711820
Dec 201702216
Jan 20182125
Feb 20182218
Mar 201801714
Apr 20182106
May 20183132
Jun 20181138
Jul 2018232
Aug 20180105
Sep 20180258
Oct 20180194
Nov 20186226
Dec 201813119
Jan 2019102712
Feb 20197216
Mar 2019161210
Apr 201991215
May 2019377
Jun 2019283
Jul 201991511
Aug 20193127
Sep 20190124
Oct 20190158
Nov 20191128
Dec 2019095
Jan 2020093
Feb 2020064
Mar 20200215
Apr 2020086
May 2020076
Jun 2020094
Jul 2020051
Aug 2020053
Sep 2020032
Oct 20200134
Nov 2020197
Dec 20200188
Jan 20210116
Feb 20210710
Mar 20210297
Apr 20210228
May 20210205
Jun 20210198
Jul 202101612
Aug 2021093
Sep 2021073
Oct 202101117
Nov 202101013
Dec 20210114
Jan 202201210
Feb 20220102
Mar 202201615
Apr 20220814
May 20220910
Jun 2022078
Jul 20220166
Aug 2022052
Sep 2022068
Oct 20220106
Nov 2022094
Dec 2022061
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 58 (2)
Journal of Nuclear Medicine
Vol. 58, Issue 2
February 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Metabolic Tumor Volume: We Still Need a Platinum-Standard Metric
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Metabolic Tumor Volume: We Still Need a Platinum-Standard Metric
Andrea Gallamini, Lale Kostakoglu
Journal of Nuclear Medicine Feb 2017, 58 (2) 196-197; DOI: 10.2967/jnumed.116.184663

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Metabolic Tumor Volume: We Still Need a Platinum-Standard Metric
Andrea Gallamini, Lale Kostakoglu
Journal of Nuclear Medicine Feb 2017, 58 (2) 196-197; DOI: 10.2967/jnumed.116.184663
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Footnotes
    • REFERENCES
  • Info & Metrics
  • PDF

Related Articles

  • Baseline Total Metabolic Tumor Volume Measured with Fixed or Different Adaptive Thresholding Methods Equally Predicts Outcome in Peripheral T Cell Lymphoma
  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Extravasation of diagnostic radiopharmaceuticals, a wolf in sheep's clothing?
  • Tau PET Visual Reads: Research and Clinical Applications and Future Directions
  • The Future of Targeted Alpha Therapy is Bright but Rigorous Studies are Necessary to Advance the Field
Show more Invited Perspectives

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire